News & Events

See what’s new at DiFilippo Corporate Finance Group

At DCF Group, we are continually working to advance the practice of financial and tax-related valuation issues to benefit our clients. Learn about new transactions, new staff members, industry news, and upcoming events. Check back often to see the latest updates.


Monte Rosa Therapeutics Announces Pricing of Initial Public Offering

Biotechnology Company, Monte Rosa Therapeutics, Inc., announced the pricing of its initial public offering of 11,700,000 shares of common stock . Read More

DCF Group’s clients raised over 25% of all capital raised by Boston startups and tech firms in January 2021

VC funding update: Boston startups and tech firms raised $3.5B in January Read More

Tessera Therapeutics Attracts Over $230M in Series B Financing

Tessera Therapeutics announced that it has raised over $230M in Series B financing to Advance ‘Gene Writing’ – A New Category in Genetic Medicine. Read More

Cullinan Management Announces Pricing of Upsized Initial Public Offering

Cullinan Management announced the pricing of its upsized initial public offering of 11,900,000 shares of common stock. Read More

Starburst Announces $100M in Series C Financing

Starburst has raised $100M in Series C financing led by Andreessen Horowitz. Read More

Servier and Celsius Therapeutics Announces Target Discovery Collaboration in Colorectal Cancer

Servier and Celsius Therapeutics announced a strategic collaboration focused on the identification and validation of novel colorectal cancer (CRC) drug targets. Read More

Exact Sciences to Acquire Thrive Earlier Detection

Exact Sciences Corp. and Thrive Earlier Detection Corp. entered into a definitive agreement under which Exact Sciences will acquire Thrive. Read More